| Pelthos Therapeutics Inc. |
Director |
Restricted Stock Units |
28K |
$616K |
$0.97 |
Jul 2, 2025 |
Direct |
| Pelthos Therapeutics Inc. |
Director |
Common Stock |
40K |
$400K |
$10.00 |
Jul 1, 2025 |
By Balmoral Financial Group LLC |
| Pelthos Therapeutics Inc. |
Director |
Common Stock |
40K |
$400K |
$10.00 |
Jul 1, 2025 |
By Key Recovery Group LLC |
| Pelthos Therapeutics Inc. |
Director |
Common Stock |
54.6K |
$60K |
$1.10 |
Jul 1, 2025 |
Direct |
| Pelthos Therapeutics Inc. |
Director |
Stock Option |
58.2K |
|
|
Jul 2, 2025 |
Direct |
| Pelthos Therapeutics Inc. |
Director |
Series A Convertible Preferred Stock |
0 |
|
|
Jul 1, 2025 |
By Balmoral Financial Group LLC |
| Pelthos Therapeutics Inc. |
Director |
Series A Convertible Preferred Stock |
0 |
|
|
Jul 1, 2025 |
By Key Recovery Group LLC |